HSBC's double upgrade and outlier PT is a high-conviction contrarian call that warrants attention, but the firm's below-average accuracy means traders should not overweight it. Use the $137 target as a ceiling and watch for follow-through from higher-accuracy firms like Morgan Stanley or Piper Sandler before adding to positions.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 15 $118.21entry
- T+1 · 6mo ago +0.59%α +0.65% · $118.91
- T+5 · 6mo ago +2.00%α +1.03% · $120.57
- T+20 · 5mo ago +1.66%α −0.46% · $120.17
- T+60 · 3mo ago +1.86%α −2.39% · $120.41
Price Chart
How similar events traded
Executive Summary
HSBC issued a rare double upgrade on NVDA, moving from Hold to Buy with a new price target of $137, up from $77, a 78% increase. The stock currently trades at $115.53, implying 19% upside to HSBC's target. This call is sharply contrarian: the consensus mean target is $89.54, and the median is $90, meaning HSBC's target is 53% above the consensus. The firm's track record is average at 55% accuracy on 263 calls, but its average return of 17.8% on rated stocks is the highest among all firms covering NVDA. Consensus stands at 23 Buy/9 Hold/0 Sell, so HSBC is aligning with the majority direction but at a far more aggressive price target. Momentum is flat, 1 upgrade and 1 downgrade in the past 30 days, with EPS revisions slightly positive. Insider sales in March total ~$1.25M, but these are routine and not clustered, so they carry low signal value. Congressional buys from Reps. Khanna and Salazar in March-April provide a modest bullish tailwind. The bottom line: HSBC's massive PT revision and double upgrade is a high-conviction contrarian call that deserves attention, but the firm's below-average accuracy tempers the signal.
Impact Score
Consensus & Targets
Consensus is heavily bullish: 7 Strong Buy, 16 Buy, 9 Hold, 0 Sell, 0 Strong Sell across 32 analysts. HSBC's upgrade aligns with the majority direction (23 Buy vs 9 Hold), but its $137 target is far above the consensus mean of $89.54, making it an outlier in magnitude.
Current price: $115.53. Consensus mean target: $89.54 (implied downside of -22%). Consensus median: $90. High target: $110 (Evercore ISI). Low target: $75. HSBC's $137 target is 53% above the mean and 25% above the prior high. Implied upside to HSBC target: +19%.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-15 | HSBC | upgrade | Buy | $137.00 |
| 2026-05-15 | Barclays | maintain | Equal-Weight | $121.00 |
| 2026-05-14 | UBS | maintain | Buy | $132.00 |
| 2026-05-14 | Citigroup | maintain | Buy | $112.00 |
| 2026-05-14 | Morgan Stanley | maintain | Overweight | $120.00 |
| 2026-05-14 | Evercore ISI Group | maintain | Outperform | $150.00 |
| 2026-05-14 | B of A Securities | maintain | Buy | $114.00 |
| 2026-05-14 | Piper Sandler | maintain | Neutral | $132.00 |
| 2026-05-14 | Wells Fargo | maintain | Overweight | $130.00 |
| 2026-05-14 | Keybanc | maintain | Overweight | $125.00 |
30-day analyst activity: 1 upgrade (HSBC), 1 downgrade (unknown). EPS revisions are slightly positive: 1 upward revision vs 0 downward in the past 7 days for the current quarter and next quarter. The EPS estimate for the current year (0y) edged up from $4.1573 to $4.1598 over 30 days. Overall, estimates are stable with a mild upward bias.
Firm Track Record: HSBC
HSBC accuracy: 55% on 263 calls | avg return: 5.5%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Morgan Stanley | 86% | 6/7 | 8.5% | top tier |
| Piper Sandler | 78% | 7/9 | 9.6% | top tier |
| Needham | 75% | 3/4 | 5.5% | top tier |
| Barclays | 71% | 5/7 | 7.1% | top tier |
| Evercore ISI Group | 67% | 4/6 | 9.7% | top tier |
| Wells Fargo | 67% | 4/6 | 5% | top tier |
| Citigroup | 63% | 5/8 | 4.1% | top tier |
| UBS | 60% | 3/5 | 5.9% | above average |
| JP Morgan | 57% | 4/7 | 4.4% | above average |
| Rosenblatt | 57% | 4/7 | 8.2% | above average |
HSBC has a 55% accuracy rate on 263 calls, ranking below average among firms covering NVDA. However, its average return of 17.8% on rated stocks is the highest of any firm in the coverage universe. Top-tier firms by accuracy: Morgan Stanley (86% on 7 calls), Piper Sandler (78% on 9), Needham (75% on 4). HSBC's call is contrarian in magnitude but directionally aligned with the bullish consensus.
Earnings Estimates
Next earnings: Aug 11, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $4.51 | $4.37 to $4.68 | $65.0B | ↑1 ↓0 |
| 0q | $1.04 | $1.03 to $1.06 | $15.6B | ↑1 ↓0 |
| +1q | $1.07 | $1.06 to $1.10 | $15.8B | ↑1 ↓0 |
| 0y | $4.16 | $4.14 to $4.20 | $61.6B | ↑1 ↓0 |
Cross-Platform Signals
Insider sales: ~$1.25M in March from C-suite (Patterson, Tuszik, Stahlkopf, Subaiya), routine sales, not clustered, low signal value per academic literature. Congressional buys: Rep. Ro Khanna (D-CA) bought $30K-$100K in March-April; Rep. Maria Elvira Salazar (R-FL) bought $16K-$65K in March, modest bullish signal. Institutional: Norges Bank initiated a $4.47B position (new), while Dodge & Cox trimmed 25.1% and Renaissance Technologies exited. Two Sigma doubled its position (+563%). Short interest is 63.9% of TRF volume, elevated but not extreme. The insider sales are a weak bearish signal that does not offset the bullish analyst and congressional signals.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
41 reports on CSCO
1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +33.58% at T+20 after the Apr 29, 2026 report. 1 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $94.78 Now $95.64 +0.91% settles Feb 16
- Nov 16, 2026today 144 Neutral 2/10 Entry $94.78 Now $95.64 +0.91% settles Feb 16
- Nov 12, 20264d ago 8-K Bullish 7/10 Entry $95.64 Now $95.64 −0.00% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $98.15 Now $95.64 −2.56% settles Feb 8
- Oct 29, 202618d ago DEFA14A Neutral 2/10 Entry $104.51 Now $95.64 −8.49% settles Jan 28
- Oct 29, 202618d ago DEF 14A Neutral 3/10 Entry $104.51 Now $95.64 −8.49% settles Jan 28
- Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $111.38 Now $95.64 −14.13% settles Jan 25
- Oct 13, 20264w ago 3 Neutral 2/10 Entry $113.64 Now $95.64 −15.84% settles Jan 11
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $115.34 Now $95.64 −17.08% settles Jan 7
- Sep 30, 20266w ago ANALYST-UPGRADE Neutral 1/10 Entry $107.21 Now $95.64 −10.80% settles Dec 24
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers